Monday, 21 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14446
Articles
Company
Drug
Hengrui Pharmaceuticals Advances Clinical Trial for PD-L1 Inhibitor Combo in CLDN18.2 Positive Tumors
April 2, 2025
Company
Drug
Allergan Aesthetics Launches SKINMEDICA in China, Targeting Booming Skincare Market
October 16, 2024
Company
Drug
InnoCare Pharma Initiates Phase Ib Study Combining ICP-189 with Furmonertinib for NSCLC
October 16, 2024
Company
Drug
Novatim Immune Therapeutics’ KQ-2003 Gains Tacit Approval for POEMS Syndrome Clinical Trial in China
October 16, 2024
Company
Harbour BioMed Reports Triple-Digit Revenue Growth and First-Ever Net Profit in 2023 Financial Results
October 16, 2024
Company
Drug
Hepalink’s Enoxaparin Sodium Injection Receives Marketing Approval in New Zealand
October 16, 2024
Company
Drug
IASO Biotherapeutics Gets NMPA Go-Ahead for BCMA-Targeted CAR-T Therapy Clinical Trial
October 16, 2024
Company
Policy / Regulatory
WuXi AppTec Denies US Allegations of Unauthorized Intellectual Property Transfer
October 16, 2024
Policy / Regulatory
China’s National Joint Procurement Office Announces Renewal of Insulin Procurement Contracts Valued at $1.59 Billion
October 16, 2024
Company
Policy / Regulatory
FDA Reviews Eisai’s Leqembi for Expanded Use as Monthly Alzheimer’s Therapy
October 16, 2024
Company
Policy / Regulatory
WuXi AppTec Denies Unauthorized IP Transfer Allegations Amidst Strong Financial Performance
October 16, 2024
Company
Drug
Genor Biopharma’s Lerociclib Accepted for Review by China’s NMPA for Breast Cancer Treatment
December 29, 2024
1
2
…
730
731
732
733
734
…
1,203
1,204
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?